Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Screening for Liver Cancer Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4689187
    • |
  • 27 April, 2026
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Screening for Liver Cancer market size was valued at US$ 10900 million in 2025 and is forecast to a readjusted size of US$ 17450 million by 2032 with a CAGR of 7.0% during review period.
Screening for Liver Cancer
Globally, liver cancer is one of the leading causes of cancer-related deaths. According to the American Cancer Society, the incidence of liver cancer has tripled since the 1980s, and the death rate has now doubled. In the United States, about 41,260 new cases are expected to be diagnosed, while about 30,520 deaths from liver cancer are expected, according to 2022 cancer statistics. The global prevalence of liver cancer and the continuous exposure of related populations to risk factors will rapidly drive the screening and diagnostics market.
This report is a detailed and comprehensive analysis for global Screening for Liver Cancer market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Screening for Liver Cancer market size and forecasts, in consumption value ($ Million), 2021-2032
Global Screening for Liver Cancer market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Screening for Liver Cancer market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Screening for Liver Cancer market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Screening for Liver Cancer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Screening for Liver Cancer market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Inc., Berry Oncology, New Horizon Health, BGI, GTH.O, Livzon, BNR.O, SingLera, Fujifilm Medical Systems U.S.A., Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Screening for Liver Cancer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hematology Test
Imaging Test
Market segment by Application
Hospital
Clinic
Other
Market segment by players, this report covers
Abbott Laboratories
Thermo Fisher Scientific, Inc.
Berry Oncology
New Horizon Health
BGI
GTH.O
Livzon
BNR.O
SingLera
Fujifilm Medical Systems U.S.A., Inc.
F. Hoffmann-La Roche Ltd.
Siemens Healthineers
BD
Illumina, Inc.
Epigenomics AG
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Screening for Liver Cancer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Screening for Liver Cancer, with revenue, gross margin, and global market share of Screening for Liver Cancer from 2021 to 2026.
Chapter 3, the Screening for Liver Cancer competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Screening for Liver Cancer market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Screening for Liver Cancer.
Chapter 13, to describe Screening for Liver Cancer research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Screening for Liver Cancer by Type
    • 1.3.1 Overview: Global Screening for Liver Cancer Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Screening for Liver Cancer Consumption Value Market Share by Type in 2025
    • 1.3.3 Hematology Test
    • 1.3.4 Imaging Test
  • 1.4 Global Screening for Liver Cancer Market by Application
    • 1.4.1 Overview: Global Screening for Liver Cancer Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Screening for Liver Cancer Market Size & Forecast
  • 1.6 Global Screening for Liver Cancer Market Size and Forecast by Region
    • 1.6.1 Global Screening for Liver Cancer Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Screening for Liver Cancer Market Size by Region, (2021-2032)
    • 1.6.3 North America Screening for Liver Cancer Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Screening for Liver Cancer Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Screening for Liver Cancer Market Size and Prospect (2021-2032)
    • 1.6.6 South America Screening for Liver Cancer Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Screening for Liver Cancer Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Screening for Liver Cancer Product and Solutions
    • 2.1.4 Abbott Laboratories Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.2 Thermo Fisher Scientific, Inc.
    • 2.2.1 Thermo Fisher Scientific, Inc. Details
    • 2.2.2 Thermo Fisher Scientific, Inc. Major Business
    • 2.2.3 Thermo Fisher Scientific, Inc. Screening for Liver Cancer Product and Solutions
    • 2.2.4 Thermo Fisher Scientific, Inc. Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
  • 2.3 Berry Oncology
    • 2.3.1 Berry Oncology Details
    • 2.3.2 Berry Oncology Major Business
    • 2.3.3 Berry Oncology Screening for Liver Cancer Product and Solutions
    • 2.3.4 Berry Oncology Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Berry Oncology Recent Developments and Future Plans
  • 2.4 New Horizon Health
    • 2.4.1 New Horizon Health Details
    • 2.4.2 New Horizon Health Major Business
    • 2.4.3 New Horizon Health Screening for Liver Cancer Product and Solutions
    • 2.4.4 New Horizon Health Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 New Horizon Health Recent Developments and Future Plans
  • 2.5 BGI
    • 2.5.1 BGI Details
    • 2.5.2 BGI Major Business
    • 2.5.3 BGI Screening for Liver Cancer Product and Solutions
    • 2.5.4 BGI Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 BGI Recent Developments and Future Plans
  • 2.6 GTH.O
    • 2.6.1 GTH.O Details
    • 2.6.2 GTH.O Major Business
    • 2.6.3 GTH.O Screening for Liver Cancer Product and Solutions
    • 2.6.4 GTH.O Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GTH.O Recent Developments and Future Plans
  • 2.7 Livzon
    • 2.7.1 Livzon Details
    • 2.7.2 Livzon Major Business
    • 2.7.3 Livzon Screening for Liver Cancer Product and Solutions
    • 2.7.4 Livzon Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Livzon Recent Developments and Future Plans
  • 2.8 BNR.O
    • 2.8.1 BNR.O Details
    • 2.8.2 BNR.O Major Business
    • 2.8.3 BNR.O Screening for Liver Cancer Product and Solutions
    • 2.8.4 BNR.O Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 BNR.O Recent Developments and Future Plans
  • 2.9 SingLera
    • 2.9.1 SingLera Details
    • 2.9.2 SingLera Major Business
    • 2.9.3 SingLera Screening for Liver Cancer Product and Solutions
    • 2.9.4 SingLera Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 SingLera Recent Developments and Future Plans
  • 2.10 Fujifilm Medical Systems U.S.A., Inc.
    • 2.10.1 Fujifilm Medical Systems U.S.A., Inc. Details
    • 2.10.2 Fujifilm Medical Systems U.S.A., Inc. Major Business
    • 2.10.3 Fujifilm Medical Systems U.S.A., Inc. Screening for Liver Cancer Product and Solutions
    • 2.10.4 Fujifilm Medical Systems U.S.A., Inc. Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Fujifilm Medical Systems U.S.A., Inc. Recent Developments and Future Plans
  • 2.11 F. Hoffmann-La Roche Ltd.
    • 2.11.1 F. Hoffmann-La Roche Ltd. Details
    • 2.11.2 F. Hoffmann-La Roche Ltd. Major Business
    • 2.11.3 F. Hoffmann-La Roche Ltd. Screening for Liver Cancer Product and Solutions
    • 2.11.4 F. Hoffmann-La Roche Ltd. Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
  • 2.12 Siemens Healthineers
    • 2.12.1 Siemens Healthineers Details
    • 2.12.2 Siemens Healthineers Major Business
    • 2.12.3 Siemens Healthineers Screening for Liver Cancer Product and Solutions
    • 2.12.4 Siemens Healthineers Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Siemens Healthineers Recent Developments and Future Plans
  • 2.13 BD
    • 2.13.1 BD Details
    • 2.13.2 BD Major Business
    • 2.13.3 BD Screening for Liver Cancer Product and Solutions
    • 2.13.4 BD Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 BD Recent Developments and Future Plans
  • 2.14 Illumina, Inc.
    • 2.14.1 Illumina, Inc. Details
    • 2.14.2 Illumina, Inc. Major Business
    • 2.14.3 Illumina, Inc. Screening for Liver Cancer Product and Solutions
    • 2.14.4 Illumina, Inc. Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Illumina, Inc. Recent Developments and Future Plans
  • 2.15 Epigenomics AG
    • 2.15.1 Epigenomics AG Details
    • 2.15.2 Epigenomics AG Major Business
    • 2.15.3 Epigenomics AG Screening for Liver Cancer Product and Solutions
    • 2.15.4 Epigenomics AG Screening for Liver Cancer Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Epigenomics AG Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Screening for Liver Cancer Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Screening for Liver Cancer by Company Revenue
    • 3.2.2 Top 3 Screening for Liver Cancer Players Market Share in 2025
    • 3.2.3 Top 6 Screening for Liver Cancer Players Market Share in 2025
  • 3.3 Screening for Liver Cancer Market: Overall Company Footprint Analysis
    • 3.3.1 Screening for Liver Cancer Market: Region Footprint
    • 3.3.2 Screening for Liver Cancer Market: Company Product Type Footprint
    • 3.3.3 Screening for Liver Cancer Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Screening for Liver Cancer Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Screening for Liver Cancer Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Screening for Liver Cancer Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Screening for Liver Cancer Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Screening for Liver Cancer Consumption Value by Type (2021-2032)
  • 6.2 North America Screening for Liver Cancer Market Size by Application (2021-2032)
  • 6.3 North America Screening for Liver Cancer Market Size by Country
    • 6.3.1 North America Screening for Liver Cancer Consumption Value by Country (2021-2032)
    • 6.3.2 United States Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Screening for Liver Cancer Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Screening for Liver Cancer Consumption Value by Type (2021-2032)
  • 7.2 Europe Screening for Liver Cancer Consumption Value by Application (2021-2032)
  • 7.3 Europe Screening for Liver Cancer Market Size by Country
    • 7.3.1 Europe Screening for Liver Cancer Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 7.3.3 France Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Screening for Liver Cancer Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Screening for Liver Cancer Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Screening for Liver Cancer Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Screening for Liver Cancer Market Size by Region
    • 8.3.1 Asia-Pacific Screening for Liver Cancer Consumption Value by Region (2021-2032)
    • 8.3.2 China Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 8.3.5 India Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Screening for Liver Cancer Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Screening for Liver Cancer Consumption Value by Type (2021-2032)
  • 9.2 South America Screening for Liver Cancer Consumption Value by Application (2021-2032)
  • 9.3 South America Screening for Liver Cancer Market Size by Country
    • 9.3.1 South America Screening for Liver Cancer Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Screening for Liver Cancer Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Screening for Liver Cancer Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Screening for Liver Cancer Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Screening for Liver Cancer Market Size by Country
    • 10.3.1 Middle East & Africa Screening for Liver Cancer Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Screening for Liver Cancer Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Screening for Liver Cancer Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Screening for Liver Cancer Market Drivers
  • 11.2 Screening for Liver Cancer Market Restraints
  • 11.3 Screening for Liver Cancer Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Screening for Liver Cancer Industry Chain
  • 12.2 Screening for Liver Cancer Upstream Analysis
  • 12.3 Screening for Liver Cancer Midstream Analysis
  • 12.4 Screening for Liver Cancer Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Screening for Liver Cancer. Industry analysis & Market Report on Screening for Liver Cancer is a syndicated market report, published as Global Screening for Liver Cancer Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Screening for Liver Cancer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo